These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3464321)

  • 21. Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E.
    Pelus LM; Saletan S; Silver RT; Moore MA
    Blood; 1982 Feb; 59(2):284-92. PubMed ID: 6173083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of purified recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells.
    Broxmeyer HE; Lu L; Bicknell DC; Williams DE; Cooper S; Levi S; Salfeld J; Arosio P
    Blood; 1986 Dec; 68(6):1257-63. PubMed ID: 3490884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
    Grant S; Bhalla K; Gleyzer M
    Leuk Res; 1986; 10(9):1139-46. PubMed ID: 2429121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
    Bhalla K; Grant S
    Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative enhancing effects of prostaglandin E1 on colony formation by erythroid progenitor (BFU-E) cells from bone marrow of mice differing in the Fv-2 locus.
    Hangoc G; Lu L; Broxmeyer HE
    Leuk Res; 1987; 11(6):501-7. PubMed ID: 3600026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The response of human marrow colony-forming units-granulocyte and macrophage to inhibition by prostaglandin E and acidic isoferritins is associated with expression of MHC class II antigens and requires the participation of a CD8+ T lymphokine.
    Pelus LM; Levi E; Welte K
    J Immunol; 1988 Sep; 141(5):1658-64. PubMed ID: 3261758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
    Tiefenthaler M; Hohla F; Strasser-Wozak E; Bacher N; Mühlmann O; Wein W; Konwalinka G
    Stem Cells; 2003; 21(3):266-71. PubMed ID: 12743321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A; Løvhaug D; Seeberg E; Nordlie EM
    Exp Hematol; 1994 Feb; 22(2):208-14. PubMed ID: 7507861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
    He Q; Xu YH
    Yao Xue Xue Bao; 1996; 31(5):340-5. PubMed ID: 9275711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acidic isoferritins do not suppress differentiation of mouse myeloid leukemic M1 cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Broxmeyer HE
    Leuk Res; 1983; 7(6):811-5. PubMed ID: 6582344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibronectin increases both non-adherent cells and CFU-GM while collagen increases adherent cells in human normal long-term bone marrow cultures.
    Hassan HT; Sadovinkova EYu ; Drize NJ; Zander AR; Neth R
    Haematologia (Budap); 1997; 28(2):77-84. PubMed ID: 9283907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors.
    Verfaillie C; McGlave P
    Blood; 1991 Jan; 77(2):263-70. PubMed ID: 1702332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.